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An electrophysiology-based forward genetic screen
has identified two genes, pickpocket11 (ppk11) and
pickpocket16 (ppk16), as being necessary for the
homeostatic modulation of presynaptic neurotrans-
mitter release at the Drosophila neuromuscular junc-
tion (NMJ). Pickpocket genes encode Degenerin/
Epithelial Sodium channel subunits (DEG/ENaC).
Wedemonstrate thatppk11 andppk16 are necessary
in presynaptic motoneurons for both the acute
induction and long-term maintenance of synaptic
homeostasis. We show that ppk11 and ppk16 are co-
transcribed as a singlemRNA that is upregulateddur-
ing homeostatic plasticity. Acute pharmacological
inhibition of a PPK11- andPPK16-containing channel
abolishes the expression of short- and long-term
homeostatic plasticity without altering baseline pre-
synaptic neurotransmitter release, indicating remark-
able specificity for homeostatic plasticity rather than
NMJ development. Finally, presynaptic calcium
imaging experiments support a model in which a
PPK11- and PPK16-containing DEG/ENaC channel
modulates presynaptic membrane voltage and,
thereby, controls calcium channel activity to homeo-
statically regulate neurotransmitter release.
INTRODUCTION
Homeostatic signaling systems are believed to interface with the
mechanisms of learning-related plasticity to achieve stable, yet
flexible, neural function and animal behavior. Experimental evi-
dence from organisms as diverse as Drosophila, mouse, and hu-
mans demonstrates that homeostatic signaling systems stabilize
neural function through the modulation of synaptic transmission,
ion channel abundance, and neurotransmitter receptor traf-
ficking (Petersen et al., 1997; Davis, 2006; Marder and Goaillard,
2006; Turrigiano, 2008; Thiagarajan et al., 2007; Kim and Ryan,
2010; Gonzalez-Islas et al., 2010). In each experiment, the cells
respond to an experimental perturbation by modulating ion
channel abundance or synaptic transmission to counteract the
perturbation and re-establish baseline function. Altered homeo-
static signaling is hypothesized to contribute to the cause or
progression of neurological disease. For example, impaired orNeumaladaptive homeostatic signaling may participate in the
progression of autism-spectrum disorders (Ramocki and
Zoghbi, 2008), Alzheimer’s disease (Kamenetz et al., 2003),
posttraumatic epilepsy (Davis and Bezprozvanny, 2001; Houw-
eling et al., 2005), and epilepsy (Bernard et al., 2004; Jakubs
et al., 2006).
The homeostatic modulation of presynaptic neurotransmitter
release has been observed at mammalian central synapses
(Piedras-Renterı´a et al., 2004; Kim and Ryan, 2010; Zhao et al.,
2011) and at neuromuscular synapses in species ranging from
Drosophila to mouse and human (Petersen et al., 1997; Frank
et al., 2006; Davis, 2006; Plomp et al., 1992). The Drosophila
neuromuscular junction (NMJ) is a prominent model system for
the study of this form of homeostatic plasticity (Petersen et al.,
1997; Davis and Goodman, 1998; Davis, 2006; Weyhersmu¨ller
et al., 2011). At the Drosophila NMJ, decreased postsynaptic
neurotransmitter receptor sensitivity is precisely counteracted
by a homeostatic potentiation of neurotransmitter release,
thereby maintaining appropriate muscle excitation. The homeo-
static enhancement of presynaptic release is due to increased
vesicle release without a change in active zone number
(Petersen et al., 1997; Frank et al., 2006; Mu¨ller et al., 2012).
Throughout this manuscript, we refer to this process as ‘‘synap-
tic homeostasis,’’ recognizing that it reflects a subset of homeo-
static regulatory mechanisms that have been shown to stabilize
neural function through modulation of ion channel gene expres-
sion and neurotransmitter receptor abundance (quantal scaling;
Turrigiano, 2008; Marder and Goaillard, 2006).
We have pioneered an electrophysiology-based, forward
genetic screen to identify the mechanisms of synaptic homeo-
stasis (Dickman and Davis, 2009; Mu¨ller et al., 2011). To date,
we have ascribed a role for several genes in the mechanism of
synaptic homeostasis including the Eph receptor (Frank et al.,
2006), the schizophrenia-associated gene dysbindin (Dickman
and Davis, 2009), the presynaptic CaV2.1 calcium channel
(Frank et al., 2006, 2009), presynaptic Rab3 GTPase-activating
protein (Rab3-GAP; Mu¨ller et al., 2011), and Rab3-interacting
molecule (RIM; Mu¨ller et al., 2012). An emerging model suggests
that, in response to inhibition of postsynaptic glutamate receptor
function, a retrograde signal acts upon the presynaptic nerve ter-
minal to enhance the number of synaptic vesicles released per
action potential to precisely offset the severity of glutamate
receptor inhibition. Two components of the presynaptic release
mechanism are necessary for the execution of synaptic homeo-
stasis, increased calcium influx through presynaptic CaV2.1
calcium channels (Mu¨ller and Davis, 2012) and a RIM-dependent
increase in the readily releasable pool of synaptic vesiclesron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Inc. 1183
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ENaC-Dependent Homeostatic Plasticity(Mu¨ller et al., 2012). Many questions remain unanswered. In
particular, how is a change in presynaptic calcium influx induced
and sustained during synaptic homeostasis?
Here, we report the identification of two genes, pickpocket16
(ppk16) and pickpocket11 (ppk11), that, when mutated, block
homeostatic plasticity. Drosophila pickpocket genes encode
Degenerin/Epithelial Sodium channel (DEG/ENaC) subunits
(Adams et al., 1998; Liu et al., 2003a; Bianchi and Driscoll,
2002). Channels in this superfamily are voltage insensitive and
are assembled as either homomeric or heteromeric trimers
(Bianchi and Driscoll, 2002; Benson et al., 2002; Jasti et al.,
2007). Each channel subunit has two transmembrane domains
with short cytoplasmic N and C termini and a large extracellular
loop implicated in responding to diverse extracellular stimuli.
Little is known regarding the function of pH-insensitive DEG/
ENaC channels in the nervous system. DEG/ENaC channels
have been implicated as part of the mechanotransduction
machinery (Chalfie, 2009) and in taste perception in both inverte-
brate and vertebrate systems (Liu et al., 2003b; Chandrashekar
et al., 2010). In Drosophila, PPK11 has been shown to function
as an ENaC channel subunit that is required for the perception
of salt taste (Liu et al., 2003b) and fluid clearance in the tracheal
system, a function that may be considered analogous to ENaC
channel activity in the mammalian lung (Liu et al., 2003a).
We demonstrate that ppk11 and ppk16 are coregulated during
homeostatic synaptic plasticity and that homeostatic plasticity is
blocked when gene is genetically deleted, when gene expres-
sion is disrupted in motoneurons, or when pickpocket channel
function is pharmacologically inhibited. We then take advantage
of the fact that presynaptic homeostasis can be blocked phar-
macologically to demonstrate that the persistent induction of
homeostatic plasticity does not interfere with synapse growth
and development. We show that homeostatic plasticity can be
acutely and rapidly erased, leaving behind otherwise normal
synaptic transmission. Finally, we demonstrate that pharmaco-
logical inhibition of this pickpocket channel abolishes the
homeostatic modulation of presynaptic calcium influx that was
previously shown to be necessary for the homeostatic increase
in neurotransmitter release (Mu¨ller and Davis, 2012).
A model for DEG/ENaC channel function can be based on the
well-established regulation of ENaC channel trafficking in the
kidney during the homeostatic control of salt balance. Enhanced
sodium reabsorption in the principle cells of the cortical collect-
ing duct of the kidney is achieved by increased ENaC channel
transcription and trafficking to the apical cell surface, which
enhances sodium influx. Sodium is then pumped out of the baso-
lateral side of the cell, accomplishing sodium reabsorption
(Schild, 2010). By analogy, we propose a model for synaptic
homeostasis in which the trafficking of DEG/ENaC channels to
the neuronal membrane, at or near the NMJ, modulates presyn-
aptic membrane potential to potentiate presynaptic calcium
channel activity and thereby achieve precise homeostatic mod-
ulation of neurotransmitter release.
RESULTS
We are pursuing an ongoing electrophysiology-based forward
genetic screen for mutations that block the rapid induction of1184 Neuron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Incsynaptic homeostasis. In brief, we record from the NMJ of anno-
tated transposon-insertion mutations in the presence of the
glutamate receptor antagonist philanthotoxin-433 (PhTx;
10 mM) according to published methods (Dickman and Davis,
2009; Mu¨ller et al., 2011). For each NMJ, we quantify miniature
excitatory postsynaptic potential (mEPSP) amplitude, EPSP
amplitude, quantal content (calculated by dividing the EPSP
amplitude/mEPSP amplitude), mEPSP frequency, muscle input
resistance, and muscle resting membrane potential. In wild-
type (WT), the application of PhTx induces a homeostatic in-
crease in presynaptic release that restores EPSP amplitudes to
wild-type levels (0.5 mM Ca2+). We are then able to identify
mutations that have a reduced EPSP amplitude in the presence
of PhTx and therefore appear to disrupt homeostatic plasticity.
To further validate our screen, we analyzed a subset ofmutations
in the presence and absence of PhTx, regardless of whether or
not they appeared to block synaptic homeostasis. In Figure 1A,
we present data for a sample of 22 transposon insertion lines in
which synaptic transmission was assayed both in the absence
and in the presence of PhTx (mutation annotations are listed in
Table S1 available online; sample sizes are 3–14 muscles for
each genotype in each condition). For each genotype, we pre-
sent the percent change in mEPSP amplitude as an indication
of the severity of glutamate receptor inhibition (black bars), as
well as the percent change in quantal content (gray bars), which
indicates the magnitude of the homeostatic increase in presyn-
aptic release. In all cases, mEPSP amplitude is reduced and
mostmutants are capable of robust homeostatic plasticity (Dick-
man and Davis, 2009; Mu¨ller et al., 2011). Notably, the trans-
poson insertion lines that we screened showed a wide range of
baseline-evoked responses in the absence of PhTx (Figure 1B),
with EPSP amplitudes ranging between 18.0 ± 2.5 mV (CcapR,
n = 6) and 43.0 ± 2.3 mV (nAChRa-18C, n = 4). Despite the
considerable span in baseline release, most transposon inser-
tion lines were capable of synaptic homeostasis, as indicated
by a PhTx-dependent increase in quantal content (Figure 1A).
However, a few lines showed virtually no PhTx-dependent
change in quantal content, indicating impaired homeostatic
compensation. The mutation in rab3-GAP has been previously
published and is a confirmed homeostatic plasticity gene (Fig-
ure 1A, green bars; Mu¨ller et al., 2011). Another line that showed
a decrease in mEPSP amplitude, but no increase in presynaptic
release, resides within the ppk11 gene locus (Figure 1A, blue
bars). ppk11was, therefore, selected as a candidate homeostat-
ic plasticity gene.
In order to pursue a formal genetic analysis of ppk11, we
acquired additional genetic and transgenic reagents (Figure 1C).
These reagents include: (1) an independently derived Minos
transposable element insertion (ppk11Mi) that resides within a
coding exon of the ppk11 gene and is predicted to be a strong
loss-of-function or null mutation, (2) a previously published
UAS-ppk11-RNAi transgenic line (Liu et al., 2003b), (3) a previ-
ously published dominant-negative transgene (UAS-dnPPK11;
Liu et al., 2003b) targeting the PPK11 trimerization domain that
disrupts channel assembly, and (4) a deficiency chromosome
(Df) that uncovers the entire ppk11 gene locus.
The ppk11 gene terminates in close proximity (63 bp
upstream) to the predicted start of another member of the.
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Figure 1. ppk11 Is Necessary for the
Homeostatic Modulation of Presynaptic
Neurotransmitter Release
(A) The percent change inmEPSP amplitude (black
bars) and quantal content (QC; gray bars) in the
presence of PhTx relative to baseline for each
genotype in the absence of PhTx. The ppk11PBac
mutation is shown in blue and the rab3-GAP mu-
tation is shown in green. All changes in mEPSP are
significant (p < 0.01) as are changes in EPSP
amplitude (p% 0.05) unless indicated otherwise.
(B) Average EPSP amplitude is plotted for each
genotype shown in (A) in the absence of PhTx.
(C) Schematic showing the genetic locus that in-
cludes ppk11 (blue) and ppk16 (red). Transposon
insertion sites are indicated by black arrowheads,
regions targeted by RNAi are indicated by black
lines, the dnPPK11 construct is indicated by a
dotted line, the ppk16166deletion is indicated by an
open red bar, and a deficiency spanning the locus
is shown as a gray arrow.
(D) Representative traces showing EPSPs and
mEPSPs from ppk11Precise (top) and ppk11Mi
(bottom). All genotypes are shown without and
with PhTx (left and right, respectively).
(E) The percent change in mEPSP (solid bars) and
quantal content (QC; open bars) in the presence of
PhTx relative to baseline for each genotype re-
corded in the absence of PhTx. All conditions show
a significant decrease in mEPSP amplitude (p <
0.001). Only wild-type (WT) and the precise exci-
sion (ppk11Precise) show an increase in quantal
content (p < 0.001). All data are recorded in 0.3–
0.35 mM extracellular calcium (see Table S1). Data
are presented as average ± SEM. Comparisons
are made according to a Student’s t test.
Neuron
ENaC-Dependent Homeostatic PlasticityDEG/ENaC channel family, pickpocket16 (ppk16) (Figure 1C,
red). The close proximity of these two genes suggested that
they might both contribute to the same DEG/ENaC channel.
Therefore, we assembled genetic reagents to test the hypothe-
sis that PPK16 might function with PPK11 during synaptic
homeostasis. These reagents include: (1) a Minos transposon
insertion that resides within the ppk16 gene (ppk16Mi), (2) a
newly generated small deficiency (ppk16166) that removes two
coding exons of the ppk16 gene and is predicted to be a strong
loss-of-function or null mutation, and (3) a UAS-ppk16-RNAi
transgenic line. Together, these reagents allow us to test the
involvement of both ppk11 and ppk16 during synaptic
homeostasis.Neuron 79, 1183–1196, SepLoss of ppk11 Blocks the Rapid
Induction of Synaptic Homeostasis
To examine the rapid induction of synap-
tic homeostasis, we applied PhTx (10–
20 mM) to the dissected NMJ for 10 min
(see Experimental Procedures) and
made recordings from muscle 6 in
abdominal segments A2 and A3. For pur-
poses of display, data for a given mutant
background are presented as normalized
to the same genotype recorded in theabsence of PhTx, as done previously (Frank et al., 2006, 2009;
Bergquist et al., 2010). All of our data are also presented as non-
normalized values (Table S2). In wild-type, application of PhTx
causes a significant decrease in mEPSP amplitude compared
to baseline and we observe a homeostatic increase in presynap-
tic neurotransmitter release (Figure 1E). However, in mutations
that disrupt the ppk11 gene, we find that synaptic homeostasis
is completely and consistently blocked. Specifically, in every
mutation that we have analyzed, including the homozygous
ppk11Mi mutation, the homozygous ppk11PBac mutation, and
ppk11PBac/Df, there is no statistically significant increase in pre-
synaptic neurotransmitter release after PhTx-dependent inhibi-
tion of mEPSP amplitudes. We also generated a precise excisiontember 18, 2013 ª2013 Elsevier Inc. 1185
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Figure 2. Analysis of Baseline Neurotrans-
mission in ppk11 Mutants
(A) Sample traces for the indicated genotypes.
(B) mEPSP amplitude, EPSP amplitude, and
quantal content for wild-type (WT), ppk11PBac,
ppk11Mi, and ppk11Precise at 0.35 mM extracellular
calcium.
(C) Representative examples of EPSCs from wild-
type (WT; top) and ppk11Mi (bottom) in the
absence of PhTx (left) and presence of PhTx (right)
at 1 mM extracellular calcium.
(D) Percent change in mEPSP amplitude and
EPSC amplitude in the presence of PhTx
compared to baseline in the absence of PhTx
for each genotype. EPSC amplitude is not
altered in WT after the addition of PhTx (p =
0.39), demonstrating homeostatic compensation
(102.3 ± 9.2 nA, n = 5 without PhTx and 112.8 ±
5.8 nA, n = 4 with PhTx). EPSC amplitude
is significantly reduced in ppk11Mi after the
addition of PhTx (p < 0.05), demonstrating
impaired homeostatic compensation (101.0 ±
13.9 nA, n = 8 without PhTx and 62.4 ± 5.9 nA,
n = 9 with PhTx).
(E) In the absence of PhTx, neither EPSC amplitude nor EPSC 20%–80% rise time is different compared to WT (p = 0.95 and p = 0.48,
respectively). Data are presented as average ± SEM. Comparisons are made according to a Student’s t test.
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assessed by sequence analysis. After the addition of PhTx to
the precise excision background (ppk11Precise), the EPSP ampli-
tude is returned to the size it was in the absence of PhTx
(ppk11Precise; Figure 1D), and the homeostatic enhancement of
presynaptic neurotransmitter release is restored to wild-type
levels (Figure 1E). Taken together, these data support the
conclusion that disruption of the ppk11 gene blocks the rapid in-
duction of synaptic homeostasis.
Despite observing a complete block of synaptic homeostasis,
there is no consistent alteration in baseline synaptic transmission
caused by the loss of ppk11. First, we compare wild-type (Fig-
ure 2B, black bars) with the ppk11PBac mutation (Figure 2B,
dark blue bars) and find no significant change in presynaptic
release and only a minor change in mEPSP amplitude. Second,
we compare the ppk11Mi mutation (Figure 2B, light blue bars)
with its appropriate genetic control, the precise excision of the
ppk11Mi transposon (ppk11Precise; Figure 2B, open bars). There
is no change in baseline release when this comparison is
made. We note that there is a significant (p < 0.01) difference
in baseline release when we compare wild-type with either
ppk11Mi or the ppk11Precise control line, and we attribute this to
differences in genetic background. Third, we analyzed a trans-
heterozygous combination of independently derived ppk11
mutations (ppk11Mi/ ppk11PBac) and find no change in quantal
content compared to wild-type (Figure S1). In this trans-hetero-
zygous combination, there is a decrease in mEPSP amplitude
that correlates with a decrease in postsynaptic muscle input
resistance (WT = 8.1 MU compared to ppk11Mi/ ppk11PBac =
3.9 MU; p < 0.01). From these data, we conclude that disruption
of ppk11 blocks synaptic homeostasis without altering baseline
release, specifically when mutations are compared to their
appropriate genetic control. This conclusion is supported by
several additional experiments, presented below.1186 Neuron 79, 1183–1196, September 18, 2013 ª2013 Elsevier IncWe next examined synaptic homeostasis and baseline trans-
mission at elevated external calcium (1 mM) that is within the
range of what is thought to be physiological calcium (Figures
2C–2E). We first quantified mEPSP amplitudes in current-clamp
mode, in which the signal-to-noise ratio is excellent, and then
switched to two-electrode voltage-clamp mode to measure
evoked synaptic currents. We observe a decrease in mEPSP
amplitude when PhTx is applied to the wild-type NMJ at 1 mM
calcium and we find that EPSC amplitudes are unchanged in
the presence of PhTx, as expected for precise homeostatic
compensation. However, in the ppk11Mi mutant, a similar
decrease in mEPSP amplitude is achieved after PhTx applica-
tion, but the average EPSC amplitude remains significantly
smaller than the average baseline EPSC recorded in the absence
of PhTx. Thus, homeostatic compensation is disrupted in the
ppk11Mimutant at physiological calciumwithout a parallel deficit
in baseline transmission. Taken together with our results from
Figure 1, these data show that synaptic homeostasis is blocked
at two different extracellular calcium concentrations (0.3mMand
1 mM). Finally, it is also worth noting that we observed a signifi-
cant decrease in muscle input resistance in the ppk11PBac, the
ppk11Mi mutant, and the ppk11Precise control compared to
wild-type, indicating an effect in the muscle cell, although the
persistence of this effect in the ppk11Precise control suggests
that it is also not linked to this genetic locus and cannot account
for a change in homeostatic plasticity (Table S2).
ppk11 Is Necessary in Motoneurons for the Rapid
Induction of Synaptic Homeostasis
To confirm that ppk11 is necessary for the rapid induction of syn-
aptic homeostasis, and to determine whether PPK11 functions in
motoneurons or muscle (or both), we took advantage of both a
previously published UAS-ppk11-RNAi line and a previously
published dominant-negative transgene that targets PPK11.
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Figure 3. ppk11 Is Required in Motoneurons for Synaptic Homeostasis
(A) Sample traces for the indicated genotypes.
(B) Percent change in mEPSP (filled bars) and QC (open bars) as in Figure 1E. mEPSP amplitude is decreased after the addition of PhTx in all conditions (p <
0.001). WT and UAS-ppk11-RNAi driven in muscle (MHC-GAL4) show a significant increase in quantal content (QC; p < 0.001). UAS-ppk11-RNAi and UAS-
dnPPK11 driven in motoneurons (OK371-GAL4) show no significant increase in QC after PhTx treatment (p = 0.69 and p = 0.09, respectively), demonstrating
impaired synaptic homeostasis.
(C) mEPSP amplitude, EPSP amplitude, and quantal content are shown. mEPSP amplitude is unchanged in the UAS-ppk11-RNAi driven in motoneurons and
reduced in the UAS-dnPPK11 driven in motoneurons (p < 0.01). There is no decrease in EPSP amplitude or quantal content when either transgenic condition is
compared to wild-type. There is a small but significant increase in EPSP amplitude (p < 0.05) and quantal content (p < 0.01) when UAS-dnPPK11 is driven in
motoneurons. Data are presented as average ± SEM. Comparisons are made according to a Student’s t test.
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UAS-ppk11-RNAi selectively in motoneurons (OK371-GAL4)
completely blocks the homeostatic increase in presynaptic
release after PhTx-dependent inhibition of postsynaptic gluta-
mate receptors (Figures 3A and 3B). By contrast, expression of
UAS-ppk11-RNAi in muscle (MHC-GAL4) does not (Figure 3B).
These data indicate that ppk11 is required in motoneurons
for synaptic homeostasis. Because ppk11 is expressed in
Drosophila trachea, where it has been implicated in fluid clear-
ance, we visually confirmed that OK371-GAL4 does not express
in trachea by driving UAS-CD8-GFP (data not shown). Next, we
attained independent confirmation that PPK11 functions in
motoneurons during homeostatic plasticity by expressing the
UAS-dnPPK11 transgene in motoneurons with OK37-GAL4.
Again, we observe a complete block of homeostatic compensa-
tion (Figure 3B). Notably, the motoneuron-specific expression of
UAS-ppk11-RNAi blocks synaptic homeostasis without altering
any aspect of synaptic transmission in the absence of PhTx
(Figure 3C). When the UAS-dnPPK11 transgene is expressed
in motoneurons, there is a small decrease in mEPSP amplitude
and a small increase in quantal content, neither of which is of
a magnitude that is expected to interfere with homeostatic plas-
ticity. Based on these data, we conclude that ppk11 is necessary
in motoneurons for synaptic homeostasis and that the blockade
of synaptic homeostasis is independent of any effect of PPK11
on baseline synaptic transmission.
ppk16 Is Necessary for the Rapid Induction of Synaptic
Homeostasis
To determine whether ppk16 is required for synaptic homeosta-
sis, we examined a Minos transposon insertion that resides
within an intron of the ppk16 gene (ppk16Mi; Figure 1C). After
the addition of PhTx, we observed a complete block in synaptic
homeostasis (Figures 4A and 4B). To confirm this finding, we uti-
lized imprecise excision of the ppk16Mi element to generate aNeudeletion mutation that removes 767 base pairs of the ppk16
gene, encompassing a large portion of the predicted extracel-
lular domain (Figure 1C). This deletion mutation, termed
ppk16166, is expected to be a strong loss-of-function or null
allele. We find that the ppk16166 mutation also blocks synaptic
homeostasis (Figure 4B). Finally, significant synaptic homeosta-
sis is restored in animals with a precise excision of the ppk16Mi
transposon (158% increase in release; p < 0.05 compared to
the same genotype in the absence of PhTx), indicating that the
block in synaptic homeostasis is derived from this genetic locus.
To confirm that ppk16 is necessary for synaptic homeostasis,
and to determine whether it is required in motoneurons along
with ppk11, we expressed UAS-ppk16-RNAi in either motoneu-
rons or muscle. When expressed in motoneurons, UAS-ppk16-
RNAi completely blocks synaptic homeostasis (Figures 4D and
4E). However, muscle-specific expression does not (Figure 4E).
Furthermore, expression of UAS-ppk16-RNAi blocks synaptic
homeostasis without altering baseline EPSP amplitude or pre-
synaptic vesicle release (quantal content; Figure 4F). Although
there is a small but statistically significant change in mEPSP
amplitude, this minor deficit is unlikely to account for the com-
plete block of the homeostatic modulation of quantal content.
Taken together, these data support the conclusion that ppk16
is necessary in motoneurons for homeostatic plasticity and
could function with PPK11 in a novel DEG/ENaC channel that
is required for synaptic homeostasis.
We performed an additional experiment to explore the poten-
tial subunit composition of the putative motoneuron DEG/ENaC
channel. Pickpocket19 (PPK19) has been previously implicated
in acting with PPK11 in the taste cells of the terminal organ (Liu
et al., 2003b). A UAS-ppk19-RNAi was previously shown to
inhibit sodium preference when expressed in sensory neurons
(Liu et al., 2003b). However, when this RNAi is expressed in
motoneurons, homeostasis remains normal (Figure 4E). These
data suggest that PPK19 is unlikely to be a third subunit ofron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Inc. 1187
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Figure 4. ppk16 Is Necessary in Motoneurons for the Homeostatic Modulation of Presynaptic Release
(A) Sample traces for the indicated genotypes.
(B) Percent change in mEPSP (filled bars) and quantal content (QC; open bars) as in Figure 1D. mEPSP amplitude is decreased after the addition of PhTx in all
conditions (p < 0.001). WT shows an increase in QC (p < 0.001), while ppk16Mi and ppk16166 do not (p = 0.68 and p = 0.24, respectively).
(C) mEPSP amplitude, EPSP amplitude, andQC are shown. ppk16166 has an increasedmEPSP amplitude (p < 0.01) compared toWT. ppk16Mi and has decreased
EPSP amplitude compared to WT (p < 0.001). ppk16Mi and ppk16166 show reduced QC (p < 0.001 and p < 0.05, respectively) compared to WT.
(D) Sample traces for the indicated genotypes.
(E) Data are as in (B). mEPSP amplitude is decreased after the addition of PhTx in all conditions (p < 0.001). WT, UAS-ppk16-RNAi driven in the muscle (MHC-
GAL4), and UAS-ppk19-RNAi driven in motoneurons (OK371-GAL4) show an increase in QC (p < 0.001), demonstrating normal synaptic homeostasis. UAS-
ppk16-RNAi driven in motoneurons (OK371-GAL4) does not show an increase in QC, demonstrating a block of synaptic homeostasis (p = 0.19).
(F) Data are as in (C). mEPSP amplitude is decreased when the UAS-ppk16-RNAi is expressed in motoneurons (p < 0.001), while EPSP amplitude and quantal
content remain unchanged (p = 0.30 and p = 0.44, respectively). There is an increase in EPSP amplitude and quantal content (p < 0.05) whenUAS-PPK19-RNAi is
expressed in motoneurons. Data are presented as average ± SEM. Comparisons are made according to a Student’s t test.
Neuron
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homeostasis.
As observed in ppk11 mutants, loss of ppk16 has a relatively
minor effect on baseline synaptic transmission. Although we
observe a significant decrease in EPSP amplitude and quantal
content in the homozygous ppk16Mi transposon mutant, we
find that baseline transmission is unaltered when compared to
the ppk16 precise excision mutant, which is the appropriate
genetic control (20.1 ± 1.9 and 26.2 ± 3.3 quanta, respectively,
p = 0.11). Consistent with this conclusion, the deletion mutation
(ppk16166) shows a wild-type EPSP amplitude, composed of a
mEPSP that is slightly larger than wild-type and a quantal con-
tent that is slightly smaller than wild-type (Figure 4C). Finally,
motoneuron-specific expression of UAS-ppk16-RNAi does not
alter quantal content but blocks homeostatic plasticity (Fig-
ure 4F). The emerging picture is that loss of ppk16 does not
cause a consistent or dramatic defect in presynaptic release,
but synaptic homeostasis is severely perturbed.
ppk11 and ppk16Mutations Do Not Alter NMJ Growth or
Morphology
To determine whether either ppk11 or ppk16 participate
in anatomical NMJ development, we quantified the number1188 Neuron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Incof synaptic boutons at muscle 6/7, the NMJ at which all
of our electrophysiological recordings were performed. In
abdominal segment 2, no changes were observed in
ppk11PBac and a small increase was observed in ppk16Mi
compared to wild-type (120.3% ± 9.9% of wild-type, p <
0.05; Figure 5B). We also quantified morphology at abdominal
segment 3 and found no significant differences in either
ppk11 or ppk16 mutants (data not shown). Next, we examined
the NMJ of muscle 4, which is situated in the middle of
the muscle, making it ideal for visualizing all active zones
within each NMJ by staining for the presynaptic active-zone-
associated protein Bruchpilot (Brp; Davis et al., 1997; Wagh
et al., 2006). Mutations in ppk11 or ppk16 had no significant
effect on NMJ area, determined by staining for the PSD-95
homolog Discs Large (DLG), and no significant change in the
number of active zones per NMJ (Figures 5C and 5D). When
we calculated active zone density by dividing active zone
number by NMJ area, we find no change in ppk11PBac and
a small (8.4% ± 2.4%, p < 0.05 compared to wild-type)
decrease in ppk16Mi (Figure 5E). Since there were no major
changes in NMJ appearance, size, or organization, we
conclude that neither ppk11 nor ppk16 plays a prominent role
in NMJ growth..
Figure 5. Normal NMJ Morphology in ppk11
and ppk16 Mutants
(A) Representative images of from muscle 4 of
wild-type (WT), ppk11PBac, and ppk16Mi mutant
animals stained for BRP (green), DLG (red), and
HRP (blue). The bottom panel shows boutons
enlarged 53.
(B) The number of boutons per NMJ at muscles 6/7
in segment 2 is expressed as percent wild-type (%
WT) bouton number. No significant changes were
observed.
(C) The area of the NMJ at muscle 4 is shown as
percent WT area, as measured by DLG staining. It
is not significantly different from wild-type in either
genotype.
(D) The number of active zones per NMJ at
muscle 4 is shown as the percent WT active
zones (measured as individual Brp puncta). Active
zone number is not different from WT in either
genotype.
(E) The active zone density at muscle 4 is
shown as percent WT active zone density. There is no significant difference in ppk11PBac, and a small decrease is observed in ppk16Mi (p <
0.05). Data are presented as average ± SEM. Comparisons are made according to a Student’s t test.
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Synaptic Homeostasis
Genetic deletion of the muscle-specific glutamate receptor sub-
unit GluRIIA (GluRIIASP16) has been shown to decrease mEPSP
amplitudes by 50% and induce a homeostatic increase in pre-
synaptic release that restores EPSP amplitudes to wild-type
levels (Petersen et al., 1997; DiAntonio et al., 1999; Frank et al.,
2006; Figures 6A and 6B). Since the GluRIIAmutation is present
throughout larval development, this experiment reflects the
sustained expression of synaptic homeostasis for several days.
To test whether ppk11 is necessary for the sustained expression
of synaptic homeostasis, we generated a GluRIIASP16,
ppk11PBac double mutant. The double mutant shows a decrease
in mEPSP amplitude without a homeostatic increase in presyn-
aptic release (Figures 6A and 6B), demonstrating that ppk11 is
necessary for both the rapid induction and the sustained expres-
sion of synaptic homeostasis.
ppk11 and ppk16 Are Coregulated and Required for the
Sustained Expression of Synaptic Homeostasis
In GluRIIA mutant animals, synaptic homeostasis persists over
several days of larval development. We reasoned that if ppk11
and ppk16 are instructive for synaptic homeostasis, their tran-
scription might be increased in GluRIIA mutants compared to
wild-type animals. Indeed, we found that the expression of
both ppk11 and ppk16mRNA are increased4-fold in theGluR-
IIA mutant background compared to wild-type, as assessed by
qPCR (Figure 6C; see Experimental Procedures). PPK11 and
PPK16 are motoneuron proteins, necessary for homeostatic
plasticity, that show a regulated change in gene expression
that correlates with homeostatic plasticity.
We also noted that these genes show an identical increase in
expression in the GluRIIA mutant. Since the ppk11 and ppk16
genes are separated by only 63 base pairs, we considered the
possibility that these genes might be cotranscribed. To test
this idea, we generated PCR primers that could specificallyNeuamplify either full-length ppk11, ppk16, or both genes together
as part of a single transcript. We find that we are able to isolate
full-length cDNAs for ppk11, ppk16, and a cDNA that spans the
coding regions of both ppk11 and ppk16 and is of the expected
size for a transcript containing both ppk11 and ppk16 (Figure 6D).
The identity of the joint ppk11-ppk16 transcript was confirmed
by sequencing the junction between the ppk11 and ppk16
genes. A stop codon is present in the joint cDNA following the
ppk11 coding sequence, suggesting that the two genes are
cotranscribed and translated as independent proteins. This
result is reproducible across three independently derived
cDNA libraries (data not shown). These data indicate that
ppk11 and ppk16 are cotranscribed and coregulated during syn-
aptic homeostasis, further suggesting that they could be sub-
units of a single channel that is upregulated during the sustained
expression of synaptic homeostasis.
ppk11 and ppk16Represent a Single Functional Genetic
Unit with Respect to Synaptic Homeostasis
We next asked whether ppk11 and ppk16 are not only cotran-
scribed and coregulated during synaptic homeostasis, but
whether they function as part of a single genetic unit during syn-
aptic homeostasis. If two genes function as part of a single
genetic unit, then disrupting the expression of one gene will
also affect the other gene. To test this, we performed a series
of complementation experiments, diagrammed in Figure 6F.
First, we show that heterozygous mutations in either the ppk11
(+,ppk11PBac/+,+) or the ppk16 genes (ppk16Mi,+/+,+) do not
alter synaptic homeostasis (Figures 6E and 6F). Next, we
demonstrate that a heterozygous deficiency that encompasses
both ppk11 and ppk16 (ppk16Df,ppk11Df/+,+) also does not alter
synaptic homeostasis (Figures 6E and 6F). Therefore, animals
that harbor one functional copy of ppk11 and one functional
copy of ppk16 can express normal synaptic homeostasis. How-
ever, when the heterozygous +,ppk11Pbac/+,+mutation is placed
in trans to the heterozygous ppk16Mi,+/+,+ mutationron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Inc. 1189
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Figure 6. Pickpocket Function and Regulation during the Long-
Term Expression of Synaptic Homeostasis
(A) Representative traces for indicated genotypes.
(B) mEPSP amplitude and quantal content (QC) are shown as percent
baseline for each genotype. GluRIIASP16 is shown as percent change relative
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1190 Neuron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Inc(+,ppk11PBac/ ppk16Mi,+), then we find that synaptic homeosta-
sis is completely blocked (Figures 6E and 6F). Although each
mutation is heterozygous, they are resident on different chromo-
somes. As such, the heterozygous mutation in ppk11 could
disrupt the remaining functional copy of ppk16 and vice versa
(Figure 6F). Since homeostasis is blocked when heterozygous
mutations are placed in trans but not when they are placed in
cis, we conclude that one or both of the mutations must affect
both ppk11 and ppk16. These data argue that ppk11 and
ppk16 are not only cotranscribed but function as a single,
operon-like genetic unit, further supporting the possibility that
these genes function together during synaptic homeostasis.
This is further supported by our finding that the organization of
the ppk11/16 locus is conserved across multiple species of
Drosophila (Figure S2), representing approximately 30 million
years of evolutionary divergence, suggesting that the tandem
placement of these genes is relevant to their regulation.
Although the ppk11/16 locus is transcribed as a single RNA,
we do not know whether these two could also be transcribed
independently. This is important to consider when interpreting
the results of transgenic RNAi. Specifically, this concerns
whether UAS-ppk11-RNAi targets only the ppk11 gene or
whether it will also affect expression of cotranscribed ppk16
and vice versa (Figures 3 and 4). One further observation is worth
considering in the trans-heterozygous data set. When mutations
in ppk11 and ppk16 are placed in trans, synaptic homeostasis is
blocked but baseline synaptic transmission (in the absence of
PhTx) is not statistically different from wild-type (Figure 6G).
The only significant change observed is a minor decrease in
mEPSP amplitude in trans-heterozygous mutants. These data
confirm, again, that homeostatic synaptic plasticity can be
blocked by disruption of the ppk11/16 locus without a parallel
change in baseline synaptic transmission.to wild-type. The ppk11PBac, GluRIIASP16 double mutant is normalized
to ppk11PBac alone. mEPSP amplitudes are decreased (p < 0.001) in
genotypes that include the GluRIIASP16 mutation. GluRIIASP16 shows an
increase in QC (p < 0.01), while the ppk11PBac, GluRIIASP16 double mutant
does not.
(C) ppk11 and ppk16 mRNA are increased 4-fold in the GluRIIASP16 mutant.
Experiment was performed in triplicate.
(D) Ethidium bromide gel showing PCR products generated from a wild-type
cDNA library. cDNAs of the expected size could be isolated with primers
targeting ppk11, ppk16, or using primers that span the full length of both genes
(ppk11-16).
(E) mEPSP amplitude (filled bars) and QC (open bars) are expressed as
the percent change in the absence of PhTx as in Figure 1D. mEPSP amplitude
is decreased after the addition of PhTx in all conditions (p < 0.001). QC
is increased for WT (p < 0.001), +,PPK11/+,+ (p < 0.001), PPK16,+/+,+
(p < 0.05), and PPK16Df,PPK11Df/+,+ (p < 0.001). There is no change in QC
in +,PPK11PBac/PPK16Mi,+ (p = 0.29).
(F) Schematic diagram of genetic epistasis experiment quantified below. The
ppk11 and ppk16 locus is shown. A red rectangle and a blue rectangle
represent a functional copy of the ppk16 and ppk11 genes, respectively. Gray
represents a loss-of-function mutation in either gene, and stripes represent the
unknown consequence of a transposon insertion.
(G) mEPSP amplitude, EPSP amplitude, and QC are shown as percent of WT.
There are no significant differences from wild-type in any condition except a
small decrease in mEPSP amplitude in +,PPK11PBac/PPK16Mi,+ (p < 0.05).
Data are presented as average ± SEM. Comparisons are made according to a
Student’s t test.
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Figure 7. Pharmacological Inhibition of PPK Channels Erases the Expression of Homeostatic Plasticity
(A) Representative traces for the indicated genotypes with PhTx (right) and without PhTx (left).
(B) Percent change of mEPSP amplitude and quantal content (QC). mEPSP amplitude is decreased by PhTx in all conditions (p < 0.001). QC is increased in WT
(p < 0.001) but not in the presence of 50 mM Benzamil (Benz; p = 0.17). QC is increased when Benzamil is washed out (p < 0.01).
(C) Quantal content in the absence of PhTx for each genotype in (B). Benzamil does not decrease quantal content (p = 0.63) and there is a slight but significant
increase after Benzamil washout (p < 0.05).
(D) Data are represented as in (A). mEPSP amplitude is decreased by PhTx (p < 0.001). QC is increased inWT in the presence of PhTx (p < 0.001), but not when the
PhTx treatment is followed by incubation in 50 mM Benzamil (p = 0.59).
(E) Percent change in mEPSP amplitude (filled bars) and QC (corrected for nonlinear summation; see Frank et al., 2006; open bars) in the presence of PhTx. The
increase in QC observed inGluRIIASP16 alone is prevented by 50 mMBenzamil (p < 0.001 without Benzamil and p = 0.82 with Benzamil). Recordings weremade at
0.5 mM extracellular calcium.
(F) QC is shown for wildWT andGluRIIASP16 in the absence and presence of Benzamil. There is an increase in QC inGluRIIASP16 compared toWT (p < 0.001), and
there is no significant difference between WT and GluRIIASP16 in the presence of Benzamil (p = 0.82).
(G) Data are shown as in (B). mEPSP amplitude is decreased after the addition of PhTx in all conditions (p < 0.001). The PPK11-PPK16 double heterozygous (PPK
het) condition in the presence of 25 mM Benzamil shows no increase in QC (p = 0.65). For purposes of data comparison in this panel, data for ‘‘ppk het’’ are
identical to that presented in Figure 6E (ppk16Df, ppk11Df/+,+). Data are presented as average ± SEM. Comparisons are made according to a Student’s t test.
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Synaptic Homeostasis
We hypothesize that PPK11/16-containing DEG/ENaC channels
are inserted into the presynaptic plasma membrane to cause a
homeostatic increase in presynaptic release and that these
channels must be maintained on the plasma membrane in order
to sustain the expression of synaptic homeostasis over several
days. If this is correct, then pharmacological blockade of the
PPK11/16 channel conductance should erase homeostatic
potentiation that was previously induced by either PhTx applica-
tion or by the presence of the GluRIIA mutation. This appears to
be the case.
DEG/ENaC channels are blocked by amiloride and its deriva-
tives (Kleyman and Cragoe, 1988). In Drosophila, Benzamil has
been shown to be a potent inhibitor of ENaC channel function
(Liu et al., 2003a). In our first set of experiments, wild-type
NMJs were coincubated in 50 mM Benzamil and 10 mM PhTx.
After a 10 min incubation, recordings were made in the presence
of 50 mM Benzamil. Ten minutes is normally sufficient to induce
potent homeostatic compensation (Figure 7B). However, in the
presence of 50 mMBenzamil, we saw a complete block in synap-
tic homeostasis (Figures 7A and 7B). Next, we tested whether
this effect could be washed out. Benzamil reversibly blocks
DEG/ENaC channels, while PhTx irreversibly antagonizesNeuDrosophila glutamate receptors (Drummond et al., 1998; Frank
et al., 2006). Therefore, we were able to incubate larvae in
PhTx and 50 mM Benzamil for 10 min and then wash out only
Benzamil, limiting its action to the timewhen synaptic homeosta-
sis was induced. We saw a complete restoration of synaptic
homeostasis after Benzamil was washed out. The half-maximal
effective concentration for disruption of synaptic homeostasis
is 32 mM (Figure S3), which is within the range expected for ami-
loride derivatives to act on Drosophila pickpocket channels
(Chen et al., 2010; Boiko et al., 2012). We have also confirmed
a block of synaptic homeostasis with a second amiloride deriva-
tive EIPA (5-(n-ethyl-n-isopropyl)amiloride) at 20 mM (Figure S4).
From these data, we can make several conclusions. First, these
data demonstrate that the conductance of the pickpocket chan-
nel is required for synaptic homeostasis, since functional
blockade is sufficient to erase homeostatic plasticity. Second,
since homeostasis is restored upon washout, it demonstrates
that the induction process remains intact, but expression is
blocked by inhibition of the DEG/ENaC channel. Third, we now
have a pharmacological reagent that blocks homeostatic plas-
ticity. Since synaptic transmission reverts to the levels seen in
an uncompensated synapse when Benzamil is applied (Fig-
ure 7C), it demonstrates that synaptic homeostasis is, at least
initially, a process that is layered on top of normal synapticron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Inc. 1191
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200 mM of axon exists between our stimulation electrode and
the NMJ. Therefore, the DEG/ENaC channel must function within
these 200 mM of axon or within the NMJ itself.
We next asked whether the PPK channel conductance is
continuously required for the expression of synaptic homeosta-
sis. First, Benzamil was applied after a 10 min incubation in PhTx
and synaptic homeostasis was blocked (Figure 7D). Thus, ENaC
channel function is necessary for the expression of synaptic
homeostasis, not during the induction of the process. Next, Ben-
zamil was applied to the GluRIIA mutant and, again, synaptic
homeostasis was completely blocked (Figure 7E). Remarkably,
quantal content in the GluRIIAmutant in the presence of Benza-
mil was identical to that observed for a wild-type NMJ in the
presence of Benzamil (Figure 7F). Thus, even when synaptic
homeostasis has been persistently engaged for the life of the
synapse, it can be erased by blocking the function of the Benza-
mil-sensitive DEG/ENaC channel.
Several controls were performed. It is well established that
Benzamil acts to inhibit DEG/ENaC channels (Kleyman and Cra-
goe, 1988; Garty and Palmer, 1997; Cuthbert and Fanelli, 1978).
However, we sought additional evidence that Benzamil acts on a
Drosophila PPK11/PPK16-containing channel. To do so, we
tested whether animals that are doubly heterozygous for the
ppk11 and ppk16 mutations (in cis) might have increased sensi-
tivity to Benzamil. The double heterozygote has normal synaptic
homeostasis (Figure 7G). When a low concentration of Benzamil
(25 mM) is applied to a wild-type NMJ, synaptic homeostasis
is also normal (Figure 7G). However, when 25 mM Benzamil
is applied to the double heterozygote, synaptic homeostasis is
blocked (Figure 7G). These data strongly suggest that Benzamil
is acting on a DEG/ENaC channel containing PPK11 and PPK16
subunits and that inhibition of this channel is the cause of
impaired synaptic homeostasis.
Finally, we note that acute application of Benzamil to the wild-
type NMJ does not impair presynaptic quantal content (Figures
7B and S3).We observe amodest decrease inmEPSP amplitude
but no change in quantal content. We further demonstrate that
the reduction in mEPSP amplitude is an action of Benzamil
that is independent of PPK11 or PPK16 and can be separated
from the effect on synaptic homeostasis (Figure S3). Thus, Ben-
zamil blocks PhTx-induced synaptic homeostasis at the wild-
type NMJ without impairing baseline presynaptic release. We
conclude from these data, as well as our genetic analyses, that
synaptic homeostasis requires a Benzamil-sensitive DEG/
ENaC channel, which is likely to include both the PPK11 and
PPK16 subunits, and this channel has little or no role during
baseline synaptic release in the absence of a homeostatic
perturbation.
Pickpocket Channel Blockade Prevents the
Homeostatic Modulation of Presynaptic Calcium Influx
It was previously demonstrated that the homeostatic modulation
of presynaptic release is achieved, in part, through an increase in
presynaptic calcium influx via the CaV2.1 calcium channel ortho-
log cacophony (Mu¨ller and Davis, 2012). Since Benzamil does
not alter baseline presynaptic release, it is unlikely to alter cal-
cium channel function directly. However, DEG/ENaC channels1192 Neuron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Incare nonvoltage-activated cation channels that show a strong
preference for sodium. As such, increased DEG/ENaC channel
function could depolarize the presynaptic membrane and indi-
rectly enhance calcium channel activity, thereby increasing
neurotransmitter release. This possibility is consistent with evi-
dence that subthreshold presynaptic depolarization enhances
neurotransmitter release at the NMJ (Wojtowicz and Atwood,
1983, 1984) and enhances both presynaptic calcium influx and
release at central synapses (Awatramani et al., 2005).
To determine whether the PPK11/16-containing DEG/ENaC
channel might influence presynaptic calcium influx through the
CaV2.1 calcium channel, we imaged presynaptic spatially aver-
aged calcium signal after single action potential stimulation with
the calcium indicator Oregon Green Bapta-1 (OGB-1), as previ-
ously described (Mu¨ller and Davis 2012). First, we find that cal-
cium influx is increased in GluRIIA mutant animals compared
to wild-type, confirming our previously published results (Figures
8A and 8B; p < 0.05; see also Mu¨ller and Davis, 2012). Next, we
demonstrate that application of Benzamil to the wild-type NMJ
has no effect on the amplitude of the evoked calcium transient
(Figures 8A and 8B). This is consistent with our conclusion based
on electrophysiology that Benzamil does not alter steady-state
neurotransmitter release. Finally, we show that Benzamil appli-
cation to the GluRIIA mutant causes a pronounced decrease in
the amplitude of the evoked calcium transient that could entirely
account for the observed Benzamil-dependent block of synaptic
homeostasis (Figure 8B; p < 0.001).
It should be noted that, in both wild-type and GluRIIA mutant
animals, Benzamil causes a drop in baseline OGB-1 fluores-
cence (Fbase) that is significant in wild-type and approaches
significance inGluRIIA (Figure 8C; p < 0.01 and p = 0.55, respec-
tively). It is likely that photobleaching during sequential acquisi-
tion of calcium transients prior to and after Benzamil application
contributes to the drop in Fbase. It remains formally possible that
Benzamil influences the Fbase measurement and we cannot rule
out the possibility that baseline calcium is decreased. However,
since a drop in Fbase should, if anything, increase calcium tran-
sient amplitudes (measured as DF/Fbase, see Experimental Pro-
cedures), this effect cannot account for the large decrease in
the amplitude of the evoked calcium transients when Benzamil
is applied to the GluRIIA mutant. These data support the con-
clusion that Benzamil-dependent inhibition of the PPK11/16
containing DEG/ENaC channel blocks synaptic homeostasis
by indirectly preventing the modulation of calcium influx through
presynaptic CaV2.1 calcium channels. These data are consistent
with a newmodel for homeostatic synaptic plasticity in which the
induction of synaptic homeostasis drives an increase in pick-
pocket channel function at or near the presynaptic membrane,
possibly through the insertion of new channels (Figure 8D; see
Discussion).
DISCUSSION
We provide evidence that a presynaptic DEG/ENaC channel
composed of PPK11 and PPK16 is required for the rapid induc-
tion, expression, and continued maintenance of homeostatic
synaptic plasticity at the Drosophila NMJ. Remarkably, ppk11
and ppk16 genes are not only required for homeostatic plasticity.
Figure 8. A Model for PPK11/16 Function
during Synaptic Homeostasis
(A) Representative traces of single action poten-
tial-evoked spatially averaged calcium transients
(average of eight to ten scans each) for the indi-
cated genotypes with and without Benzamil (right
and left, respectively).
(B) DF/F calcium transient peak amplitudes for
individual boutons imaged before and after
75 mM Benzamil application (n = 8 and n = 11
boutons for wild-type [WT] and the GluRIIA
mutant, respectively). There is no significant
change in DF/F in WT after Benzamil treatment
(p = 0.07), and there is a significant decrease in
the GluRIIA mutant after Benzamil treatment (p <
0.001).
(C) Average baseline fluorescence (Fbase) for WT
and GluRIIA in the presence and absence of
Benzamil. There is a statistically significant
decrease in WT after Benzamil treatment (p <
0.01) and a nonsignificant trend toward a
decrease in GluRIIA treated with Benzamil (p =
0.055).
(D) Our data support a model whereby PPK11-
and PPK16-containing channels (purple) are in-
serted into the presynaptic membrane during
synaptic homeostasis to cause an increase in
sodium influx and a resulting change in presynaptic resting potential DVm (right). The change in presynaptic resting potential directly or indirectly leads to
increased presynaptic calcium influx (red). Data are presented as average ± SEM. Comparisons are made according to a Student’s t test.
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differentially regulated during homeostatic plasticity. Specif-
ically, we show that expression of both ppk11 and ppk16 is
increased 4-fold in the GluRIIA mutant background. We also
demonstrate that ppk11 and ppk16 are transcribed together in
a single transcript and behave genetically as an operon-like, sin-
gle genetic unit. This molecular organization suggests a model in
which ppk11 and ppk16 are cotranscribed to generate DEG/
ENaC channels with an equal stoichiometric ratio of PPK11
and PPK16 subunits. This is consistent with previous models
for gene regulation in Drosophila (Blumenthal, 2004). However,
we cannot rule out the possibility that two independent DEG/
ENaC channels are upregulated, one containing PPK11 and
one containing PPK16. The upregulation of ppk11 and ppk16
together with the necessity of DEG/ENaC channel function dur-
ing the time when synaptic homeostasis is assayed, indicates
that these genes are probably part of the homeostat and not
merely necessary for the expression of synaptic homeostasis.
A Model for DEG/ENaC Channel Function during
Homeostatic Plasticity
DEG/ENaC channels are voltage-insensitive cation channels
that are primarily permeable to sodium (Ben-Shahar, 2011; Bian-
chi and Driscoll, 2002) and can carry a sodium leak current. A
model for DEG/ENaC channel function during synaptic homeo-
stasis can be based on the well-established regulation of
ENaC channel trafficking in the kidney during the homeostatic
control of salt balance. Enhanced sodium reabsorption in the
principle cells of the cortical collecting duct of the kidney is trig-
gered by aldosterone binding to the mineralocorticoid receptor.
This increases ENaC channel transcription and trafficking to theNeuapical cell surface, which enhances sodium influx. Sodium is
then pumped out of the basolateral side of the cell, accomplish-
ing sodium reabsorption (Schild, 2010).
We speculate that a retrograde, homeostatic signal from
muscle triggers increased trafficking of a PPK11/16-containing
DEG/ENaC channel to the neuronal plasma membrane, at or
near the NMJ. Since the rapid induction of synaptic homeostasis
is protein synthesis independent (Goold and Davis, 2007), we
hypothesize the existence of a resting pool of PPK11/16 chan-
nels that are inserted in the membrane in response to post-
synaptic glutamate receptor inhibition. If postsynaptic glutamate
receptor inhibition is sustained, as in the GluRIIA mutant, then
increased transcription of ppk11/16 supports a persistent
requirement for this channel at the developing NMJ. Once on
the plasma membrane, the PPK11/16 channel would induce a
sodium leak and cause a moderate depolarization of the nerve
terminal. This subthreshold depolarization would lead, indirectly,
to an increase in action potential-induced presynaptic calcium
influx through the CaV2.1 calcium channel and subsequent
neurotransmitter release (Figure 8D).
There are two major possibilities for how ENaC-dependent
depolarization of the nerve terminal could potentiate calcium
influx and evoked neurotransmitter release. One possibility,
based on work in the ferret prefrontal cortex and Aplysia central
synapses (Shu et al., 2006; Shapiro et al., 1980), is that pre-
synaptic membrane depolarization causes action potential
broadening through potassium channel inactivation, thereby
enhancing both calcium influx and release. A second possibility
is that subthreshold depolarization of the nerve terminal causes
an increase in resting calcium that leads to calcium-dependent
calcium channel facilitation (Cuttle et al., 1998; Borst andron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Inc. 1193
Neuron
ENaC-Dependent Homeostatic PlasticitySakmann, 1998). Consistent with this model, it has been shown
at several mammalian synapses that subthreshold depolariza-
tion of the presynaptic nerve terminal increases resting calcium
and neurotransmitter release through low-voltage modulation
of presynaptic P/Q-type calcium channels (Awatramani et al.,
2005; Alle and Geiger, 2006; Christie et al., 2011). However, at
these mammalian synapses, the change in resting calcium
does not lead to an increase in action potential-evoked calcium
influx, highlighting a difference between the mechanisms of
homeostatic potentiation and the type of presynapticmodulation
observed at these other synapses (Awatramani et al., 2005; Alle
andGeiger, 2006; Christie et al., 2011). Themechanism by which
elevated basal calcium potentiates release at these mammalian
synapses remains under debate (Bouhours et al., 2011; Chu
et al., 2012). It should be noted that small, subthreshold depolar-
ization of the presynaptic resting potential, as small as 5 mV, are
sufficient to cause a 2-fold increase in release at both neuromus-
cular (Wojtowicz and Atwood, 1983) and mammalian central
synapses (Awatramani et al., 2005; Christie et al., 2011). This is
within a reasonable range for modulation of presynaptic mem-
brane potential by pickpocket channel insertion. Unfortunately,
it is not technically feasible to record directly from the presynap-
tic terminal at theDrosophilaNMJ. Finally, we note that it remains
formally possible that a PPK11/16-containing DEG/ENaC chan-
nel passes calcium, based upon the ability of mammalian ASIC
channels to flux calcium (Waldmann et al., 1997).
This model might provide insight regarding how accurate
tuning of presynaptic neurotransmitter release can be achieved
(Frank et al., 2006). There is a supralinear relationship between
calcium influx and release (Katz and Miledi, 1970; Bollmann
et al., 2000; Schneggenburger and Neher, 2000). Therefore, if
changing calcium channel number is the mechanism by which
synaptic homeostasis is achieved, then there must be very tight
and tunable control of calcium channel number within each
presynaptic active zone. By contrast, if homeostatic plasticity
is achieved by ENaC-dependent modulation of membrane
voltage, then variable insertion of ENaC channels could uni-
formly modulate calcium channel activity, simultaneously across
all of the active zones of the presynaptic nerve terminal. Further-
more, if the ENaC channel sodium leak is small, and if presyn-
aptic calcium channels are moderately influenced by small
changes in resting membrane potential, then relatively coarse
modulation of ENaC channel trafficking could be used to achieve
precise, homeostatic control of calcium influx and neurotrans-
mitter release. Again, these are testable hypotheses that will
be addressed in the future.EXPERIMENTAL PROCEDURES
Electrophysiology
Recordings were made from muscle 6 in abdominal segments 2 and 3 from
third-instar larvae, as previously described (Frank et al., 2006, 2009, Mu¨ller
et al., 2012). Recordings were made in HL3 saline containing 70 mM NaCl,
5 mM KCl, 10 mM MgCl2, 10 mM NaHCO3, 115 mM sucrose, 4.2 mM treha-
lose, 5 mM HEPES, and 0.35 mM CaCl2, unless otherwise specified. Quantal
content was calculated by dividing the average EPSP amplitude by the
average mEPSP amplitude for each muscle recording. Where specified,
quantal content was corrected for nonlinear summation (NLS) according to
established methods (Martin, 1955; Davis and Goodman, 1998). For acute1194 Neuron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Incpharmacological homeostatic challenge, larvae were incubated in Philantho-
toxin-433 (PhTx; 10–20 mM; Sigma-Aldrich) for 10min (Frank et al., 2006). Ben-
zamil hydrochoride hydrate (Sigma-Aldrich) was prepared as a stock in H2O
and diluted to the desired concentration in HL3 saline. EIPA (5-(n-ethyl-n-iso-
propyl)amiloride; Sigma-Aldrich) was prepared as a stock in DMSO, then
diluted 1:1,000 in HL3 to a concentration of EIPA of 20 mM. A 1:1,000 dilution
of DMSO is without effect on synaptic transmission (Frank et al., 2006).
Two-electrode voltage-clamp recordings were done as previously
described (Mu¨ller et al., 2012). All recordings were made from muscle 6 in
abdominal segments 2 and 3 from third-instar larvae in HL3 saline with
1 mM CaCl2. mEPSPs were recorded with the amplifier in bridge mode before
switching to TEVC mode. mEPSPs were analyzed rather than mEPSCs,
because of the low signal-to-noise ratio for mEPSCs. EPSC analysis was con-
ducted using custom-written routines for Igor Pro 5.0 (WaveMetrics), and
mEPSPs were analyzed using Mini Analysis 6.0.0.7 (Synaptosoft).
Fly Stocks and Genetics
In all experiments, the w1118 strain was used at the wild-type control, and
animals were raised at 22C, unless otherwise noted.Drosophila melanogaster
stocks with the following mutations, UAS-transgenes, or GAL4 drivers were
used in the course of this study: UAS-ppk11-RNAi, UAS-ppk11-dn, and
UAS-ppk19-RNAi were the kind gifts of Lei Liu. ppk11Mi, ppk11PBac, ppk16Mi,
and Df(2l)BSC240 (PPK deficiency) were acquired from the Bloomington
Stock Center. UAS-ppk16-RNAi was acquired from the Vienna Drosophila
Stock Center (VDRC transformant ID 22990). The GluRIIASP16 null mutation
(Petersen et al., 1997), the OK371-GAL4 driver (Mahr and Aberle, 2006), and
the MHC-Gal4 driver (Schuster et al., 1996) have all been previously reported
on. The precise excision, ppk11Precise, and the imprecise excision, ppk16166,
were generated according to standard procedures (Metaxakis et al., 2005).
Deletions were identified by PCR, and all results were verified through
sequencing.
Anatomical Analysis
Third-instar larval preparations were fixed in Bouin’s fixative, washed, and
incubated overnight at 4C in primary antibodies. Secondary antibodies
were applied at room temperature for 2 hr. The following antibodies were
used: anti-NC82 (1:100; mouse; Developmental Studies Hybridoma Bank)
and anti-DLG (1:10,000; rabbit). Alexa-conjugated secondary antibodies and
Cy5-conjugated goat ant-HRP were used at 1:250 (Jackson ImmunoResearch
Laboratories; Molecular Probes). Larval preparations were mounted in Vecta-
shield (Vector) and imaged at room temperature using an Axiovert 200 (Zeiss)
inverted microscope, a 1003 Plan Apochromat objective (1.4 NA), and a
cooled charge-coupled device camera (Coolsnap HQ, Roper). Intelligent Im-
aging Innovations (3I) software was used to capture, process, and analyze
images.
CNS Quantitative RT-PCR
RT-PCR was performed as previously described (Bergquist et al., 2010).
Primer-probes specific for real-time PCR detection of ppk11, ppk16, and Ribo-
somal protein L32 (RpL32) were designed and developed by Applied
Biosystems. The CNS was removed from 25 third-instar larvae per sample
(three samples/genotype). Total RNA was isolated from each sample using
the standard Trizol protocol. A DNase digestion removed potential DNA
contamination (RQ1 RNase-free DNase Promega).
cDNA Extraction and Amplification
cDNA libraries were generated using the SMARTer RACE cDNA Amplification
Kit (Clontech). Primers used for PPK11 and PPK16 amplification were as
follows: ppk11 forward, 50-ATGTCCGACGTTCCAGGAG-30; ppk11 reverse,
50-ATTAGCCGGCCCTAATGACC-30; ppk16 forward, 50-ATGGCTTTCAA
GAAGCGGCG-30; ppk16 reverse, 50-CTACTCCCGGTTGATGTAGTT-30. PCR
was done using TAQ polymerase, according to standard procedures.
Calcium Imaging
Ca2+ imaging experiments were done as described in Mu¨ller and Davis (2012).
See Supplemental Experimental Procedures for details regarding dissection,
dye loading, and imaging..
Neuron
ENaC-Dependent Homeostatic PlasticitySUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2013.06.048.ACKNOWLEDGMENTS
This study was supported by NIH grant number NS39313 to G.W.D. We thank
Li Liu for sending Drosophila stocks and Susan Younger, Phil Parker, Kevin
Ford, and members of the Davis laboratory for help and advice.
Accepted: June 24, 2013
Published: August 22, 2013REFERENCES
Adams, C.M., Anderson, M.G., Motto, D.G., Price, M.P., Johnson, W.A., and
Welsh, M.J. (1998). Ripped pocket and pickpocket, novel Drosophila DEG/
ENaC subunits expressed in early development and in mechanosensory
neurons. J. Cell Biol. 140, 143–152.
Alle, H., and Geiger, J.R.P. (2006). Combined analog and action potential
coding in hippocampal mossy fibers. Science 311, 1290–1293.
Awatramani, G.B., Price, G.D., and Trussell, L.O. (2005). Modulation of trans-
mitter release by presynaptic resting potential and background calcium levels.
Neuron 48, 109–121.
Ben-Shahar, Y. (2011). Sensory functions for degenerin/epithelial sodium
channels (DEG/ENaC). Adv. Genet. 76, 1–26.
Benson, C.J., Xie, J., Wemmie, J.A., Price, M.P., Henss, J.M.,Welsh,M.J., and
Snyder, P.M. (2002). Heteromultimers of DEG/ENaC subunits form H+-gated
channels in mouse sensory neurons. Proc. Natl. Acad. Sci. USA 99, 2338–
2343.
Bergquist, S., Dickman, D.K., and Davis, G.W. (2010). A hierarchy of cell
intrinsic and target-derived homeostatic signaling. Neuron 66, 220–234.
Bernard, C., Anderson, A., Becker, A., Poolos, N.P., Beck, H., and Johnston,
D. (2004). Acquired dendritic channelopathy in temporal lobe epilepsy.
Science 305, 532–535.
Bianchi, L., and Driscoll, M. (2002). Protons at the gate: DEG/ENaC ion chan-
nels help us feel and remember. Neuron 34, 337–340.
Blumenthal, T. (2004). Operons in eukaryotes. Brief. Funct. Genomics
Proteomics 3, 199–211.
Boiko, N., Kucher, V., Stockand, J.D., and Eaton, B.A. (2012). Pickpocket1 is
an ionotropic molecular sensory transducer. J. Biol. Chem. 287, 39878–39886.
Bollmann, J.H., Sakmann, B., and Borst, J.G. (2000). Calcium sensitivity of
glutamate release in a calyx-type terminal. Science 289, 953–957.
Borst, J.G., and Sakmann, B. (1998). Facilitation of presynaptic calcium
currents in the rat brainstem. J. Physiol. 513, 149–155.
Bouhours, B., Trigo, F.F., and Marty, A. (2011). Somatic depolarization
enhances GABA release in cerebellar interneurons via a calcium/protein
kinase C pathway. J. Neurosci. 31, 5804–5815.
Chalfie, M. (2009). Neurosensory mechanotransduction. Nat. Rev. Mol. Cell
Biol. 10, 44–52.
Chandrashekar, J., Kuhn, C., Oka, Y., Yarmolinsky, D.A., Hummler, E., Ryba,
N.J., and Zuker, C.S. (2010). The cells and peripheral representation of sodium
taste in mice. Nature 464, 297–301.
Chen, Z., Wang, Q., and Wang, Z. (2010). The amiloride-sensitive epithelial
Na+ channel PPK28 is essential for drosophila gustatory water reception.
J. Neurosci. 30, 6247–6252.
Christie, J.M., Chiu, D.N., and Jahr, C.E. (2011). Ca(2+)-dependent enhance-
ment of release by subthreshold somatic depolarization. Nat. Neurosci. 14,
62–68.NeuChu, Y., Fioravante, D., Thanawala, M., Leitges, M., and Regehr, W.G. (2012).
Calcium-dependent isoforms of protein kinase C mediate glycine-induced
synaptic enhancement at the calyx of Held. J. Neurosci. 32, 13796–13804.
Cuthbert, A.W., and Fanelli, G.M. (1978). Effects of some pyrazinecarboxa-
mides on sodium transport in frog skin. Br. J. Pharmacol. 63, 139–149.
Cuttle, M.F., Tsujimoto, T., Forsythe, I.D., and Takahashi, T. (1998). Facilitation
of the presynaptic calcium current at an auditory synapse in rat brainstem.
J. Physiol. 512, 723–729.
Davis, G.W. (2006). Homeostatic control of neural activity: from phenomenol-
ogy to molecular design. Annu. Rev. Neurosci. 29, 307–323.
Davis, G.W., and Bezprozvanny, I. (2001). Maintaining the stability of neural
function: a homeostatic hypothesis. Annu. Rev. Physiol. 63, 847–869.
Davis, G.W., and Goodman, C.S. (1998). Synapse-specific control of synaptic
efficacy at the terminals of a single neuron. Nature 392, 82–86.
Davis, G.W., Schuster, C.M., and Goodman, C.S. (1997). Genetic analysis of
the mechanisms controlling target selection: target-derived Fasciclin II regu-
lates the pattern of synapse formation. Neuron 19, 561–573.
DiAntonio, A., Petersen, S.A., Heckmann, M., and Goodman, C.S. (1999).
Glutamate receptor expression regulates quantal size and quantal content at
the Drosophila neuromuscular junction. J. Neurosci. 19, 3023–3032.
Dickman, D.K., and Davis, G.W. (2009). The schizophrenia susceptibility gene
dysbindin controls synaptic homeostasis. Science 326, 1127–1130.
Drummond, H.A., Price, M.P., Welsh, M.J., and Abboud, F.M. (1998). A molec-
ular component of the arterial baroreceptor mechanotransducer. Neuron 21,
1435–1441.
Frank, C.A., Kennedy, M.J., Goold, C.P., Marek, K.W., and Davis, G.W. (2006).
Mechanisms underlying the rapid induction and sustained expression of
synaptic homeostasis. Neuron 52, 663–677.
Frank, C.A., Pielage, J., and Davis, G.W. (2009). A presynaptic homeostatic
signaling system composed of the Eph receptor, ephexin, Cdc42, and
CaV2.1 calcium channels. Neuron 61, 556–569.
Garty, H., and Palmer, L.G. (1997). Epithelial sodium channels: function, struc-
ture, and regulation. Physiol. Rev. 77, 359–396.
Gonzalez-Islas, C., Chub, N., Garcia-Bereguiain, M.A., and Wenner, P. (2010).
GABAergic synaptic scaling in embryonic motoneurons is mediated by a shift
in the chloride reversal potential. J. Neurosci. 30, 13016–13020.
Goold, C.P., and Davis, G.W. (2007). The BMP ligand Gbb gates the expres-
sion of synaptic homeostasis independent of synaptic growth control.
Neuron 56, 109–123.
Houweling, A.R., Bazhenov, M., Timofeev, I., Steriade, M., and Sejnowski, T.J.
(2005). Homeostatic synaptic plasticity can explain post-traumatic epilepto-
genesis in chronically isolated neocortex. Cereb. Cortex 15, 834–845.
Jakubs, K., Nanobashvili, A., Bonde, S., Ekdahl, C.T., Kokaia, Z., Kokaia, M.,
and Lindvall, O. (2006). Environment matters: synaptic properties of neurons
born in the epileptic adult brain develop to reduce excitability. Neuron 52,
1047–1059.
Jasti, J., Furukawa, H., Gonzales, E.B., and Gouaux, E. (2007). Structure of
acid-sensing ion channel 1 at 1.9 A resolution and low pH. Nature 449,
316–323.
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T.,
Sisodia, S., and Malinow, R. (2003). APP processing and synaptic function.
Neuron 37, 925–937.
Katz, B., and Miledi, R. (1970). Further study of the role of calcium in synaptic
transmission. J. Physiol. 207, 789–801.
Kim, S.H., and Ryan, T.A. (2010). CDK5 serves as a major control point in
neurotransmitter release. Neuron 67, 797–809.
Kleyman, T.R., and Cragoe, E.J., Jr. (1988). Amiloride and its analogs as tools
in the study of ion transport. J. Membr. Biol. 105, 1–21.
Liu, L., Johnson, W.A., and Welsh, M.J. (2003a). Drosophila DEG/ENaC pick-
pocket genes are expressed in the tracheal system, where they may be
involved in liquid clearance. Proc. Natl. Acad. Sci. USA 100, 2128–2133.ron 79, 1183–1196, September 18, 2013 ª2013 Elsevier Inc. 1195
Neuron
ENaC-Dependent Homeostatic PlasticityLiu, L., Leonard, A.S., Motto, D.G., Feller, M.A., Price, M.P., Johnson, W.A.,
and Welsh, M.J. (2003b). Contribution of Drosophila DEG/ENaC genes to
salt taste. Neuron 39, 133–146.
Mahr, A., and Aberle, H. (2006). The expression pattern of the Drosophila
vesicular glutamate transporter: a marker protein for motoneurons and gluta-
matergic centers in the brain. Gene Expr. Patterns 6, 299–309.
Marder, E., and Goaillard, J.-M. (2006). Variability, compensation and homeo-
stasis in neuron and network function. Nat. Rev. Neurosci. 7, 563–574.
Martin, A.R. (1955). A further study of the statistical composition on the end-
plate potential. J. Physiol. 130, 114–122.
Metaxakis, A., Oehler, S., Klinakis, A., and Savakis, C. (2005). Minos as a
genetic and genomic tool in Drosophila melanogaster. Genetics 171, 571–581.
Mu¨ller, M., and Davis, G.W. (2012). Transsynaptic control of presynaptic Ca2+
influx achieves homeostatic potentiation of neurotransmitter release. Curr.
Biol. 22, 1102–1108.
Mu¨ller, M., Pym, E.C., Tong, A., and Davis, G.W. (2011). Rab3-GAP controls
the progression of synaptic homeostasis at a late stage of vesicle release.
Neuron 69, 749–762.
Mu¨ller, M., Liu, K.S., Sigrist, S.J., and Davis, G.W. (2012). RIM controls homeo-
static plasticity through modulation of the readily-releasable vesicle pool.
J. Neurosci. 32, 16574–16585.
Petersen, S.A., Fetter, R.D., Noordermeer, J.N., Goodman, C.S., and
DiAntonio, A. (1997). Genetic analysis of glutamate receptors in Drosophila
reveals a retrograde signal regulating presynaptic transmitter release.
Neuron 19, 1237–1248.
Piedras-Renterı´a, E.S., Pyle, J.L., Diehn, M., Glickfeld, L.L., Harata, N.C., Cao,
Y., Kavalali, E.T., Brown, P.O., and Tsien, R.W. (2004). Presynaptic homeosta-
sis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway.
Proc. Natl. Acad. Sci. USA 101, 3609–3614.
Plomp, J.J., van Kempen, G.T., and Molenaar, P.C. (1992). Adaptation of
quantal content to decreased postsynaptic sensitivity at single endplates in
alpha-bungarotoxin-treated rats. J. Physiol. 458, 487–499.
Ramocki, M.B., and Zoghbi, H.Y. (2008). Failure of neuronal homeostasis
results in common neuropsychiatric phenotypes. Nature 455, 912–918.1196 Neuron 79, 1183–1196, September 18, 2013 ª2013 Elsevier IncSchild, L. (2010). The epithelial sodium channel and the control of sodium
balance. Biochim. Biophys. Acta 1802, 1159–1165.
Schneggenburger, R., and Neher, E. (2000). Intracellular calcium dependence
of transmitter release rates at a fast central synapse. Nature 406, 889–893.
Schuster, C.M., Davis, G.W., Fetter, R.D., and Goodman, C.S. (1996). Genetic
dissection of structural and functional components of synaptic plasticity. II.
Fasciclin II controls presynaptic structural plasticity. Neuron 17, 655–667.
Shapiro, E., Castellucci, V.F., and Kandel, E.R. (1980). Presynaptic membrane
potential affects transmitter release in an identified neuron in Aplysia by modu-
lating the Ca2+ and K+ currents. Proc. Natl. Acad. Sci. USA 77, 629–633.
Shu, Y., Hasenstaub, A., Duque, A., Yu, Y., and McCormick, D.A. (2006).
Modulation of intracortical synaptic potentials by presynaptic somatic mem-
brane potential. Nature 441, 761–765.
Thiagarajan, T.C., Lindskog, M., Malgaroli, A., and Tsien, R.W. (2007). LTP and
adaptation to inactivity: overlapping mechanisms and implications for meta-
plasticity. Neuropharmacology 52, 156–175.
Turrigiano, G.G. (2008). The self-tuning neuron: synaptic scaling of excitatory
synapses. Cell 135, 422–435.
Wagh, D.A., Rasse, T.M., Asan, E., Hofbauer, A., Schwenkert, I., Du¨rrbeck, H.,
Buchner, S., Dabauvalle, M.C., Schmidt, M., Qin, G., et al. (2006). Bruchpilot, a
protein with homology to ELKS/CAST, is required for structural integrity and
function of synaptic active zones in Drosophila. Neuron 49, 833–844.
Waldmann, R., Champigny, G., Bassilana, F., Heurteaux, C., and Lazdunski,
M. (1997). A proton-gated cation channel involved in acid-sensing. Nature
386, 173–177.
Weyhersmu¨ller, A., Hallermann, S., Wagner, N., and Eilers, J. (2011). Rapid
active zone remodeling during synaptic plasticity. J. Neurosci. 31, 6041–6052.
Wojtowicz, J.M., and Atwood, H.L. (1983). Maintained depolarization of synap-
tic terminals facilitates nerve-evoked transmitter release at a crayfish neuro-
muscular junction. J. Neurobiol. 14, 385–390.
Wojtowicz, J.M., and Atwood, H.L. (1984). Presynaptic membrane potential
and transmitter release at the crayfish neuromuscular junction.
J. Neurophysiol. 52, 99–113.
Zhao, C., Dreosti, E., and Lagnado, L. (2011). Homeostatic synaptic plasticity
through changes in presynaptic calcium influx. J. Neurosci. 31, 7492–7496..
